APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Drugs & Dietary Supplements

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast 2026-2032

20 December 2025209 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Drugs & Dietary Supplements Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Drugs & Dietary Supplements Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Drugs & Dietary Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Over the Counter (OTC) Drugs & Dietary Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Over the Counter (OTC) Drugs & Dietary Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Over the Counter (OTC) Drugs & Dietary Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Over the Counter (OTC) Drugs & Dietary Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Over the Counter (OTC) Drugs & Dietary Supplements include Sanofi S.A, Johnson & Johnson, Novartis International AG, Merck & Co., Inc., Roche Holding AG, Pfizer Inc., GlaxoSmithKline plc., Bayer Healthcare AG and AbbVie Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Over the Counter (OTC) Drugs & Dietary Supplements, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Over the Counter (OTC) Drugs & Dietary Supplements, also provides the revenue of main regions and countries. Of the upcoming market potential for Over the Counter (OTC) Drugs & Dietary Supplements, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Over the Counter (OTC) Drugs & Dietary Supplements revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Over the Counter (OTC) Drugs & Dietary Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Over the Counter (OTC) Drugs & Dietary Supplements revenue, projected growth trends, production technology, application and end-user industry.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Company

Sanofi S.A

Johnson & Johnson

Novartis International AG

Merck & Co., Inc.

Roche Holding AG

Pfizer Inc.

GlaxoSmithKline plc.

Bayer Healthcare AG

AbbVie Inc.

AstraZeneca plc.

The Colgate-Palmolive Company

Reckitt Benckiser Plc.

Gilead Sciences

Bausch & Lomb

Alliance Healthcare

Allergan, Plc.

Alkalon A/S

Alfresa Pharma Corporation

Alcon Inc.

Alacer Corp.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type

Cough, Cold, and Flu Products

Mineral Supplements

Dermatological Products

Vitamin Supplements

Ophthalmic Products

Analgesic & Pain Relievers

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application

Retail Pharmacies

Online Pharmacy

Hospital Pharmacies

Others

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Drugs & Dietary Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Drugs & Dietary Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Drugs & Dietary Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Over the Counter (OTC) Drugs & Dietary Supplements in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over the Counter (OTC) Drugs & Dietary Supplements revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cough, Cold, and Flu Products Major Player Table 3. Mineral Supplements Major Player Table 4. Dermatological Products Major Player Table 5. Vitamin Supplements Major Player Table 6. Ophthalmic Products Major Player Table 7. Analgesic & Pain Relievers Major Player Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Retail Pharmacies Major Player Table 10. Online Pharmacy Major Player Table 11. Hospital Pharmacies Major Player Table 12. Others Major Player Table 13. Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2021-2026) Table 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2027-2032) Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2021-2026) Table 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Key Players Headquarters & Area Served Table 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Players, Product Type & Application Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2021-2026) Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2027-2032) Table 35. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021-2026) Table 39. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2027-2032) Table 40. Sanofi S.A Company Information Table 41. Sanofi S.A Business Overview Table 42. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 44. Sanofi S.A Recent Development Table 45. Johnson & Johnson Company Information Table 46. Johnson & Johnson Business Overview Table 47. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 49. Johnson & Johnson Recent Development Table 50. Novartis International AG Company Information Table 51. Novartis International AG Business Overview Table 52. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 54. Novartis International AG Recent Development Table 55. Merck & Co., Inc. Company Information Table 56. Merck & Co., Inc. Business Overview Table 57. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 59. Merck & Co., Inc. Recent Development Table 60. Roche Holding AG Company Information Table 61. Roche Holding AG Business Overview Table 62. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 64. Roche Holding AG Recent Development Table 65. Pfizer Inc. Company Information Table 66. Pfizer Inc. Business Overview Table 67. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 69. Pfizer Inc. Recent Development Table 70. GlaxoSmithKline plc. Company Information Table 71. GlaxoSmithKline plc. Business Overview Table 72. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 74. GlaxoSmithKline plc. Recent Development Table 75. Bayer Healthcare AG Company Information Table 76. Bayer Healthcare AG Business Overview Table 77. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 79. Bayer Healthcare AG Recent Development Table 80. AbbVie Inc. Company Information Table 81. AbbVie Inc. Business Overview Table 82. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 84. AbbVie Inc. Recent Development Table 85. AstraZeneca plc. Company Information Table 86. AstraZeneca plc. Business Overview Table 87. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 89. AstraZeneca plc. Recent Development Table 90. The Colgate-Palmolive Company Company Information Table 91. The Colgate-Palmolive Company Business Overview Table 92. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 94. The Colgate-Palmolive Company Recent Development Table 95. Reckitt Benckiser Plc. Company Information Table 96. Reckitt Benckiser Plc. Business Overview Table 97. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 99. Reckitt Benckiser Plc. Recent Development Table 100. Gilead Sciences Company Information Table 101. Gilead Sciences Business Overview Table 102. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 104. Gilead Sciences Recent Development Table 105. Bausch & Lomb Company Information Table 106. Bausch & Lomb Business Overview Table 107. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 109. Bausch & Lomb Recent Development Table 110. Alliance Healthcare Company Information Table 111. Alliance Healthcare Business Overview Table 112. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 114. Alliance Healthcare Recent Development Table 115. Allergan, Plc. Company Information Table 116. Allergan, Plc. Business Overview Table 117. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 119. Allergan, Plc. Recent Development Table 120. Alkalon A/S Company Information Table 121. Alkalon A/S Business Overview Table 122. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 124. Alkalon A/S Recent Development Table 125. Alfresa Pharma Corporation Company Information Table 126. Alfresa Pharma Corporation Business Overview Table 127. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 129. Alfresa Pharma Corporation Recent Development Table 130. Alcon Inc. Company Information Table 131. Alcon Inc. Business Overview Table 132. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 134. Alcon Inc. Recent Development Table 135. Alacer Corp. Company Information Table 136. Alacer Corp. Business Overview Table 137. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 139. Alacer Corp. Recent Development Table 140. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (US$ Million) Table 141. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032) & (US$ Million) Table 142. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (US$ Million) & (2027-2032) Table 147. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (US$ Million) Table 153. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (US$ Million) & (2027-2032) Table 154. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (US$ Million) Table 155. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032) & (US$ Million) Table 156. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (US$ Million) Table 157. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (US$ Million) & (2021-2026) Table 164. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (US$ Million) & (2027-2032) Table 165. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (US$ Million) Table 171. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (US$ Million) & (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Image Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cough, Cold, and Flu Products Image Figure 5. Mineral Supplements Image Figure 6. Dermatological Products Image Figure 7. Vitamin Supplements Image Figure 8. Ophthalmic Products Image Figure 9. Analgesic & Pain Relievers Image Figure 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share 2021 VS 2025 VS 2032 Figure 12. Retail Pharmacies Image Figure 13. Online Pharmacy Image Figure 14. Hospital Pharmacies Image Figure 15. Others Image Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million) & (2021-2032) Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2021-2032) Figure 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021-2032) Figure 27. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032) Figure 29. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032) Figure 30. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Country (2021-2032) Figure 31. United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032) Figure 36. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032) Figure 37. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Country (2021-2032) Figure 38. Germany Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032) Figure 48. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032) Figure 49. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032) Figure 51. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032) Figure 52. Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Region (2021-2032) Figure 53. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032) Figure 61. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032) Figure 62. SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Country (2021-2032) Figure 63. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold, and Flu Products
  • Mineral Supplements
  • Dermatological Products
  • Vitamin Supplements
  • Ophthalmic Products
  • Analgesic & Pain Relievers
Applications
  • Retail Pharmacies
  • Online Pharmacy
  • Hospital Pharmacies
  • Others
Companies covered
  • Sanofi S.A
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co., Inc.
  • Roche Holding AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AbbVie Inc.
  • AstraZeneca plc.
  • The Colgate-Palmolive Company
  • Reckitt Benckiser Plc.
  • Gilead Sciences
  • Bausch & Lomb
  • Alliance Healthcare
  • Allergan, Plc.
  • Alkalon A/S
  • Alfresa Pharma Corporation
  • Alcon Inc.
  • Alacer Corp.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Over the Counter (OTC) Drugs & Dietary Supplements Market by Type
  3. 1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cough, Cold, and Flu Products
  5. 1.2.3 Mineral Supplements
  6. 1.2.4 Dermatological Products
  7. 1.2.5 Vitamin Supplements
  8. 1.2.6 Ophthalmic Products
  9. 1.2.7 Analgesic & Pain Relievers
  10. 1.3 Over the Counter (OTC) Drugs & Dietary Supplements Market by Application
  11. 1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Retail Pharmacies
  13. 1.3.3 Online Pharmacy
  14. 1.3.4 Hospital Pharmacies
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
  1. 2.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
  2. 2.2 Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers
  3. 2.3 Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2021-2032)
  2. 3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
  3. 3.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026)
  5. 3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players
  2. 4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2021-2026)
  3. 4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Key Players Headquarters & Area Served
  7. 4.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Players, Product Type & Application
  8. 4.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market CR5 and HHI
  11. 4.6.3 2025 Over the Counter (OTC) Drugs & Dietary Supplements Tier 1, Tier 2, and Tier 3
5 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  1. 5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2032)
  3. 5.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2021-2032)
6 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  1. 6.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2032)
  3. 6.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi S.A
  2. 7.1.1 Sanofi S.A Company Information
  3. 7.1.2 Sanofi S.A Business Overview
  4. 7.1.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  6. 7.1.5 Sanofi S.A Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis International AG
  14. 7.3.1 Novartis International AG Company Information
  15. 7.3.2 Novartis International AG Business Overview
  16. 7.3.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  18. 7.3.5 Novartis International AG Recent Developments
  19. 7.4 Merck & Co., Inc.
  20. 7.4.1 Merck & Co., Inc. Company Information
  21. 7.4.2 Merck & Co., Inc. Business Overview
  22. 7.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  24. 7.4.5 Merck & Co., Inc. Recent Developments
  25. 7.5 Roche Holding AG
  26. 7.5.1 Roche Holding AG Company Information
  27. 7.5.2 Roche Holding AG Business Overview
  28. 7.5.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  30. 7.5.5 Roche Holding AG Recent Developments
  31. 7.6 Pfizer Inc.
  32. 7.6.1 Pfizer Inc. Company Information
  33. 7.6.2 Pfizer Inc. Business Overview
  34. 7.6.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  36. 7.6.5 Pfizer Inc. Recent Developments
  37. 7.7 GlaxoSmithKline plc.
  38. 7.7.1 GlaxoSmithKline plc. Company Information
  39. 7.7.2 GlaxoSmithKline plc. Business Overview
  40. 7.7.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  42. 7.7.5 GlaxoSmithKline plc. Recent Developments
  43. 7.8 Bayer Healthcare AG
  44. 7.8.1 Bayer Healthcare AG Company Information
  45. 7.8.2 Bayer Healthcare AG Business Overview
  46. 7.8.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  48. 7.8.5 Bayer Healthcare AG Recent Developments
  49. 7.9 AbbVie Inc.
  50. 7.9.1 AbbVie Inc. Company Information
  51. 7.9.2 AbbVie Inc. Business Overview
  52. 7.9.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  53. 7.9.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  54. 7.9.5 AbbVie Inc. Recent Developments
  55. 7.10 AstraZeneca plc.
  56. 7.10.1 AstraZeneca plc. Company Information
  57. 7.10.2 AstraZeneca plc. Business Overview
  58. 7.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  60. 7.10.5 AstraZeneca plc. Recent Developments
  61. 7.11 The Colgate-Palmolive Company
  62. 7.11.1 The Colgate-Palmolive Company Company Information
  63. 7.11.2 The Colgate-Palmolive Company Business Overview
  64. 7.11.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  65. 7.11.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  66. 7.11.5 The Colgate-Palmolive Company Recent Developments
  67. 7.12 Reckitt Benckiser Plc.
  68. 7.12.1 Reckitt Benckiser Plc. Company Information
  69. 7.12.2 Reckitt Benckiser Plc. Business Overview
  70. 7.12.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  72. 7.12.5 Reckitt Benckiser Plc. Recent Developments
  73. 7.13 Gilead Sciences
  74. 7.13.1 Gilead Sciences Company Information
  75. 7.13.2 Gilead Sciences Business Overview
  76. 7.13.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  78. 7.13.5 Gilead Sciences Recent Developments
  79. 7.14 Bausch & Lomb
  80. 7.14.1 Bausch & Lomb Company Information
  81. 7.14.2 Bausch & Lomb Business Overview
  82. 7.14.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  84. 7.14.5 Bausch & Lomb Recent Developments
  85. 7.15 Alliance Healthcare
  86. 7.15.1 Alliance Healthcare Company Information
  87. 7.15.2 Alliance Healthcare Business Overview
  88. 7.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  90. 7.15.5 Alliance Healthcare Recent Developments
  91. 7.16 Allergan, Plc.
  92. 7.16.1 Allergan, Plc. Company Information
  93. 7.16.2 Allergan, Plc. Business Overview
  94. 7.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  96. 7.16.5 Allergan, Plc. Recent Developments
  97. 7.17 Alkalon A/S
  98. 7.17.1 Alkalon A/S Company Information
  99. 7.17.2 Alkalon A/S Business Overview
  100. 7.17.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  102. 7.17.5 Alkalon A/S Recent Developments
  103. 7.18 Alfresa Pharma Corporation
  104. 7.18.1 Alfresa Pharma Corporation Company Information
  105. 7.18.2 Alfresa Pharma Corporation Business Overview
  106. 7.18.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  108. 7.18.5 Alfresa Pharma Corporation Recent Developments
  109. 7.19 Alcon Inc.
  110. 7.19.1 Alcon Inc. Company Information
  111. 7.19.2 Alcon Inc. Business Overview
  112. 7.19.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  114. 7.19.5 Alcon Inc. Recent Developments
  115. 7.20 Alacer Corp.
  116. 7.20.1 Alacer Corp. Company Information
  117. 7.20.2 Alacer Corp. Business Overview
  118. 7.20.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  120. 7.20.5 Alacer Corp. Recent Developments
8 North America
  1. 8.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2021-2032)
  2. 8.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2032)
  3. 8.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026)
  4. 8.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032)
  5. 8.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032)
  6. 8.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2032)
  7. 8.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026)
  8. 8.4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032)
  9. 8.5 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032)
  10. 8.6 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  11. 8.6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026)
  13. 8.6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2021-2032)
  2. 9.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2032)
  3. 9.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026)
  4. 9.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032)
  5. 9.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032)
  6. 9.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2032)
  7. 9.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026)
  8. 9.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032)
  9. 9.5 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032)
  10. 9.6 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  11. 9.6.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026)
  13. 9.6.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2021-2032)
  2. 10.2 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2032)
  3. 10.2.1 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026)
  4. 10.2.2 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032)
  5. 10.3 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032)
  6. 10.4 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2032)
  7. 10.4.1 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026)
  8. 10.4.2 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032)
  9. 10.5 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2021-2032)
  2. 11.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2032)
  3. 11.2.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026)
  4. 11.2.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032)
  5. 11.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032)
  6. 11.4 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2032)
  7. 11.4.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026)
  8. 11.4.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032)
  9. 11.5 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032)
  10. 11.6 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  11. 11.6.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026)
  13. 11.6.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2021-2032)
  2. 12.2 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2027-2032)
  5. 12.3 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2027-2032)
  9. 12.5 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  11. 12.6.1 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst